127 related articles for article (PubMed ID: 27545193)
1. Podoplanin Expression Correlates with Disease Progression in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzółka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Reich A; Podhorska-Okołów M; Dzięgiel P; Szepietowski JC
Acta Derm Venereol; 2017 Feb; 97(2):235-241. PubMed ID: 27545193
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD31 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
[TBL] [Abstract][Full Text] [Related]
3. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
[TBL] [Abstract][Full Text] [Related]
4. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of IL-10 in mycosis fungoides.
Buhl L; Søgaard H
Exp Dermatol; 1997 Aug; 6(4):195-8. PubMed ID: 9293392
[TBL] [Abstract][Full Text] [Related]
6. Failure of detection of mucin in the clear halos around the epidermotropic lymphocytes in mycosis fungoides.
El Darouti M; Marzouk SA; Horn TD
J Cutan Pathol; 2000 Apr; 27(4):183-5. PubMed ID: 10774939
[TBL] [Abstract][Full Text] [Related]
7. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
9. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides--a review of the management of 28 patients and of the recent literature.
Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S
Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715
[TBL] [Abstract][Full Text] [Related]
11. Expression of SATB1, MTI/II and Ki-67 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Bieniek A; Dziegiel P
Anticancer Res; 2016 Jan; 36(1):189-97. PubMed ID: 26722043
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous expression of Thy-1 in mycosis fungoides.
Fivenson DP; Douglass MC; Nickoloff BJ
Am J Pathol; 1992 Dec; 141(6):1373-80. PubMed ID: 1281618
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides.
Pileri A; Agostinelli C; Righi S; Fuligni F; Bacci F; Sabattini E; Patrizi A; Pileri SA; Piccaluga PP
Histopathology; 2015 Jan; 66(2):173-81. PubMed ID: 24766213
[TBL] [Abstract][Full Text] [Related]
15. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
16. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
[TBL] [Abstract][Full Text] [Related]
17. Follicular mucinosis and follicular mycosis fungoides: clinicopathological evaluation of seven cases.
Yaman B; Gerçeker Türk B; Öztürk G; Ertam I; Kandıloğlu G; Akalin T
Turk Patoloji Derg; 2013; 29(2):108-16. PubMed ID: 23661347
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lymphangiogenic markers in Sézary syndrome.
Karpova MB; Fujii K; Jenni D; Dummer R; Urosevic-Maiwald M
Leuk Lymphoma; 2011 Mar; 52(3):491-501. PubMed ID: 20846094
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P
Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Angiogenesis in Early Mycosis Fungoides Patients: Dermoscopic and Immunohistochemical Study.
Bosseila M; Sayed Sayed K; El-Din Sayed SS; Abd El Monaem NA
Dermatology; 2015; 231(1):82-6. PubMed ID: 26044542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
